[18F]FDHT Radiation Dosimetry in Women with Breast Cancer at S0: Absorbed Dose in Target Organ at S0
Target organ | Absorbed dose (mGy/MBq) | ||
---|---|---|---|
Mean | SD | SD (%) | |
Adrenals | 2.3E−02 | 1.3E−03 | 5% |
Bone (endosteal cells) | 1.4E−02 | 1.6E−03 | 11% |
Bone marrow (red, active) | 2.1E−02 | 3.9E−03 | 19% |
Brain | 5.3E−03 | 6.8E−04 | 13% |
Breast tissue | 1.2E−02 | 3.0E−04 | 3% |
Colon | 1.7E−02 | 6.5E−04 | 4% |
Extrathoracic region | 8.0E−03 | 3.0E−04 | 4% |
Gallbladder wall | 2.5E−02 | 1.7E−03 | 7% |
Heart wall | 2.1E−02 | 1.2E−03 | 6% |
Kidneys | 3.4E−02 | 3.8E−03 | 11% |
Liver | 3.7E−02 | 3.9E−03 | 11% |
Lung | 1.5E−02 | 1.8E−03 | 12% |
Lymphatic nodes | 1.6E−02 | 7.0E−05 | 0% |
Muscle | 1.3E−02 | 1.8E−04 | 1% |
Ovaries | 2.6E−02 | 2.0E−03 | 7% |
Pancreas | 1.9E−02 | 6.9E−04 | 4% |
Skin | 9.1E−03 | 1.7E−04 | 2% |
Small intestine | 1.9E−02 | 7.0E−04 | 4% |
Spleen | 2.4E−02 | 2.2E−03 | 9% |
Stomach | 1.6E−02 | 6.4E−04 | 4% |
Thymus | 1.4E−02 | 5.9E−04 | 4% |
Thyroid | 1.2E−02 | 4.0E−04 | 3% |
Urinary bladder wall | 7.4E−02 | 1.1E−02 | 15% |
Uterus | 3.8E−02 | 4.0E−03 | 11% |
Total body | 1.3E−02 | 1.5E−04 | 1% |
Effective dose (mSv/MBq) | 2.0E−02 | 5.0E−04 | 2% |